Translating T Cell Responses Generated by Vaccines into Lasting Benefits for Patients
Time: 11:30 am
day: Focus Day
Details:
- Discussing the powerful combination immunotherapies that are needed for the
treatment of metastatic patents - Determining the vaccination platform, the magnitude and quality of neoantigen
induced T cells - Interrogating T cells infiltrating the tumour to dissect the relative contribution of
vaccine induced T cells
